Stemore Pharmaceutical Is Trailing Ripk1 Inhibitor.

ahmad029

Established Member
My Regimen
Reaction score
67
http://stemore.co.kr/rnd/pipeline/

They are trailing a new mechanism, any thoughts?

I mean no Dkk1, Beta catenin, GSk3beta,
AR inhibitor or beloved 5 alpha inhibitor.

They are going for a apparently a novel Pathway. A quick Google says this pathway is pro inflammatory and pro cancerous which means this compound will target inflammation.
 
Top